MB
GMAB icon

MidFirst Bank’s Genmab GMAB Stock Holding History

MidFirst Bank’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.06K Hold
75
– – ﹤0.01% 704
2026
Q1 		$2.01K Sell
75
-1,755
-96% -$52.6K ﹤0.01% 681
2025
Q4 		$56.4K Buy
+1,830
New +$57K ﹤0.01% 448

Other funds holding GMAB

Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

MidFirst Bank's GMAB Position: Q2 2026 in Review

MidFirst Bank held its Genmab (GMAB) position steady in Q2 2026 at 75 shares worth $2.06K. The position accounts for ﹤0.01% of the portfolio, ranked #704.

MidFirst Bank first reported a position in GMAB in Q4 2025 and has held it in 3 quarters since. The position peaked at $56.4K in Q4 2025. 225 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • MidFirst Bank held 75 shares of Genmab worth $2.06K as of Q2 2026.
  • MidFirst Bank left its Genmab share count unchanged in Q2 2026.
  • Genmab made up ﹤0.01% of MidFirst Bank's portfolio in Q2 2026, its #704 holding.
  • MidFirst Bank first reported a position in Genmab in Q4 2025 and has held it in 3 quarters since.
  • MidFirst Bank's Genmab position peaked at $56.4K in Q4 2025.
  • 225 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.